This topic contains a solution. Click here to go to the answer

Author Question: Which drug would most likely be an initial treatment for a patient with Alzheimer's disease? 1. ... (Read 53 times)

kamilo84

  • Sr. Member
  • ****
  • Posts: 495
Which drug would most likely be an initial treatment for a patient with Alzheimer's disease?
 
  1. Levodopa (Larodopa)
  2. Haloperidol (Haldol)
  3. Benztropine mesylate (Cogentin)
  4. Donepezil hydrochloride (Aricept)

Question 2

The nurse in the emergency department frequently sees clients who have overdosed on acetaminophen (Tylenol). Which client is at highest risk for developing hemolysis?
 
  1. A Native American client
  2. A Jewish client
  3. An African American client
  4. A Caucasian client



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

tuwy

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

4
Rationale 1: Levodopa (Larodopa) is used for Parkinson's disease.
Rationale 2: Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.
Rationale 3: Benztropine mesylate (Cogentin) is used for Parkinson's disease.
Rationale 4: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease.
Global Rationale: Donepezil hydrochloride (Aricept) is an acetylcholinesteras e inhibitor and the most frequently used drug for Alzheimer's disease. Levodopa (Larodopa) and benztropine mesylate (Cogentin) are used for Parkinson's disease. Haloperidol (Haldol) can be used in some cases of Alzheimer's disease, but due to its adverse effects it is not frequently used.

Answer to Question 2

3
Rationale 1: Native Americans are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 2: Jewish clients are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Rationale 3: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol).
Rationale 4: Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).
Global Rationale: African Americans have higher rates of G6PD enzyme deficiency. Clients with this deficiency are at risk for developing hemolysis after ingestion of certain drugs, including acetaminophen (Tylenol). Native Americans, Jewish clients, and Caucasians are not known to have a G6PD enzyme deficiency so they are not at risk for developing hemolysis after ingestion of acetaminophen (Tylenol).





 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

Human stomach acid is strong enough to dissolve small pieces of metal such as razor blades or staples.

Did you know?

Approximately one in three babies in the United States is now delivered by cesarean section. The number of cesarean sections in the United States has risen 46% since 1996.

Did you know?

The tallest man ever known was Robert Wadlow, an American, who reached the height of 8 feet 11 inches. He died at age 26 years from an infection caused by the immense weight of his body (491 pounds) and the stress on his leg bones and muscles.

For a complete list of videos, visit our video library